BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2266681)

  • 1. Effects of dialysis membranes on beta 2-microglobulin production and cellular expression.
    Zaoui PM; Stone WJ; Hakim RM
    Kidney Int; 1990 Nov; 38(5):962-8. PubMed ID: 2266681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodialysis with cuprophane membrane modulates interleukin-2 receptor expression.
    Zaoui P; Green W; Hakim RM
    Kidney Int; 1991 May; 39(5):1020-6. PubMed ID: 2067197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intradialytic body weight changes and dialyzer pore size as main contributing factors to the evolution of beta-2-microglobulin in dialysis.
    Vanholder RC; Ringoir SM
    Blood Purif; 1990; 8(1):32-44. PubMed ID: 2198890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of reprocessing cuprophane and polysulfone dialyzers on beta 2-microglobulin removal from hemodialysis patients.
    Petersen J; Moore RM; Kaczmarek RG; Singh B; Yeh I; Hamburger S; Kankam M
    Am J Kidney Dis; 1991 Feb; 17(2):174-8. PubMed ID: 1992659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-2-microglobulin in hemodialysis patients. Effects of different dialyzers and different dialysis procedures.
    Mayer G; Thum J; Woloszczuk W; Graf H
    Am J Nephrol; 1988; 8(4):280-4. PubMed ID: 3055992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of mononuclear cells by contact with cuprophan membranes: further increase of beta 2-microglobulin synthesis by activated late complement components.
    Schoels M; Jahn B; Hug F; Deppisch R; Ritz E; Hänsch GM
    Am J Kidney Dis; 1993 Apr; 21(4):394-9. PubMed ID: 8465819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of the dialysis membrane on cytokine release.
    Zaoui P; Hakim RM
    J Am Soc Nephrol; 1994 Mar; 4(9):1711-8. PubMed ID: 8011981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum beta 2-microglobulin levels in patients chronically dialyzed with CA-210 versus CT-190 dialysis membranes.
    DeFranco P; Farrell J; Gellens M; Bastani B
    Am J Nephrol; 1998; 18(1):16-20. PubMed ID: 9481434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of plasma beta 2 microglobulin concentration: possible relation to membrane biocompatibility.
    Bommer J; Seelig P; Seelig R; Geerlings W; Bommer G; Ritz E
    Nephrol Dial Transplant; 1987; 2(1):22-5. PubMed ID: 3110692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biocompatibility study--inflammable cytokine production by the extract from fiber membrane in human peripheral blood].
    Ikeda K
    Nihon Geka Gakkai Zasshi; 1994 Aug; 95(8):496-503. PubMed ID: 7969016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodialysis related induction of interleukin-6 production by peripheral blood mononuclear cells.
    Memoli B; Libetta C; Rampino T; Dal Canton A; Conte G; Scala G; Ruocco MR; Andreucci VE
    Kidney Int; 1992 Aug; 42(2):320-6. PubMed ID: 1405316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of dialyzer membranes on beta-2 microglobulin production in Thai hemodialysis patients.
    Domrongkitchaiporn S; Chuncharunee S; Archararit N; Atamasirikul K; Vanichakarn S
    J Med Assoc Thai; 1997 Sep; 80 Suppl 1():S138-43. PubMed ID: 9347661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal T lymphocyte function in patients with end-stage renal disease hemodialyzed with 'high-flux' polysulfone membranes.
    Degiannis D; Czarnecki M; Donati D; Homer L; Eisinger RP; Raska K; Raskova J
    Am J Nephrol; 1990; 10(4):276-82. PubMed ID: 2240054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biocompatibility of dialysis membranes: effects of chronic complement activation.
    Hakim RM; Fearon DT; Lazarus JM
    Kidney Int; 1984 Aug; 26(2):194-200. PubMed ID: 6334194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer-cell function in hemodialysis patients: effect of the dialysis membrane.
    Zaoui P; Hakim RM
    Kidney Int; 1993 Jun; 43(6):1298-305. PubMed ID: 8315942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do different dialysis-membranes affect beta 2-microglobulin kinetics during chronic hemodialysis?
    Risler T; Braun N; Hanel KD; Kuhlmann U; Skroch D; Müller GA
    Int J Artif Organs; 1994 Nov; 17(11):581-4. PubMed ID: 7744517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [What is the reason for the increase in beta-2-microglobulin levels in the blood when using cuprophane dialysis membranes?].
    Sulková S; Lapcík O; Votruba T
    Cas Lek Cesk; 1989 Apr; 128(17):520-3. PubMed ID: 2665936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of dialyzer reprocessing with Renalin on serum beta-2-microglobulin and complement activation in hemodialysis patients.
    Westhuyzen J; Foreman K; Battistutta D; Saltissi D; Fleming SJ
    Am J Nephrol; 1992; 12(1-2):29-36. PubMed ID: 1415362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of a dialysis membrane that can remove beta 2-microglobulin (beta 2m).
    Ono T; Iwamoto N; Kataoka H; Yamada S; Sakai Y; Kunitomo T
    ASAIO Trans; 1988; 34(3):342-5. PubMed ID: 3058179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Removal of silicon, aluminum and beta 2-microglobulin in chronic haemodialysis patients.
    Hosokawa S; Yoshida O
    Int Urol Nephrol; 1991; 23(3):281-4. PubMed ID: 1889973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.